Cargando…

Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease

Detalles Bibliográficos
Autores principales:	Krashia, Paraskevi, Cordella, Alberto, Nobili, Annalisa, La Barbera, Livia, Federici, Mauro, Leuti, Alessandro, Campanelli, Federica, Natale, Giuseppina, Marino, Gioia, Calabrese, Valeria, Vedele, Francescangelo, Ghiglieri, Veronica, Picconi, Barbara, Di Lazzaro, Giulia, Schirinzi, Tommaso, Sancesario, Giulia, Casadei, Nicolas, Riess, Olaf, Bernardini, Sergio, Pisani, Antonio, Calabresi, Paolo, Viscomi, Maria Teresa, Serhan, Charles Nicholas, Chiurchiù, Valerio, D’Amelio, Marcello, Mercuri, Nicola Biagio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791874/ https://www.ncbi.nlm.nih.gov/pubmed/31611555 http://dx.doi.org/10.1038/s41467-019-12538-2

Ejemplares similares

Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease
por: Krashia, Paraskevi, et al.
Publicado: (2019)

Unifying Hypothesis of Dopamine Neuron Loss in Neurodegenerative Diseases: Focusing on Alzheimer's Disease
por: Krashia, Paraskevi, et al.
Publicado: (2019)

Upregulation of Ca(2+)-binding proteins contributes to VTA dopamine neuron survival in the early phases of Alzheimer’s disease in Tg2576 mice
por: La Barbera, Livia, et al.
Publicado: (2022)

Advances in understanding the function of alpha-synuclein: implications for Parkinson’s disease
por: Calabresi, Paolo, et al.
Publicado: (2023)

Effects of head trauma and sport participation in young-onset Parkinson’s disease
por: Schirinzi, Tommaso, et al.
Publicado: (2021)

Nilotinib: from animal-based studies to clinical investigation in Alzheimer’s disease patients
por: Nobili, Annalisa, et al.
Publicado: (2022)

Dysregulation of Resolvin E1 Metabolism and Signaling in a Light-Damage Model of Age-Related Macular Degeneration
por: Tisi, Annamaria, et al.
Publicado: (2023)

The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease
por: Krashia, Paraskevi, et al.
Publicado: (2022)

Ambra1 Shapes Hippocampal Inhibition/Excitation Balance: Role in Neurodevelopmental Disorders
por: Nobili, Annalisa, et al.
Publicado: (2018)

Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease
por: Nobili, Annalisa, et al.
Publicado: (2017)

How Comorbidity Reflects on Cerebrospinal Fluid Biomarkers of Neurodegeneration in Aging
por: Zenuni, Henri, et al.
Publicado: (2021)

Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia
por: Ghiglieri, Veronica, et al.
Publicado: (2012)

Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction
por: Calabresi, Paolo, et al.
Publicado: (2023)

Hippocampal epileptogenesis in autoimmune encephalitis
por: Romoli, Michele, et al.
Publicado: (2019)

Long-Term Shaping of Corticostriatal Synaptic Activity by Acute Fasting
por: Campanelli, Federica, et al.
Publicado: (2021)

A Clinical and Biochemical Analysis in the Differential Diagnosis of Idiopathic Normal Pressure Hydrocephalus
por: Schirinzi, Tommaso, et al.
Publicado: (2015)

Restoration of ER proteostasis attenuates remote apoptotic cell death after spinal cord injury by reducing autophagosome overload
por: Bisicchia, Elisa, et al.
Publicado: (2022)

Chemogenetic rectification of the inhibitory tone onto hippocampal neurons reverts autistic-like traits and normalizes local expression of estrogen receptors in the Ambra1+/- mouse model of female autism
por: Pignataro, Annabella, et al.
Publicado: (2023)

Effects of uremic toxins on hippocampal synaptic transmission: implication for neurodegeneration in chronic kidney disease
por: Natale, Giuseppina, et al.
Publicado: (2021)

Bioactive Lipids and Chronic Inflammation: Managing the Fire Within
por: Chiurchiù, Valerio, et al.
Publicado: (2018)

Proresolving Lipid Mediators: Endogenous Modulators of Oxidative Stress
por: Leuti, Alessandro, et al.
Publicado: (2019)

Erratum to “Proresolving Lipid Mediators: Endogenous Modulators of Oxidative Stress”
por: Leuti, Alessandro, et al.
Publicado: (2019)

Can transcranial magnetic stimulation rescue dopaminergic signalling in Alzheimer's disease?
por: D’Amelio, Marcello, et al.
Publicado: (2023)

Physical Activity Changes and Correlate Effects in Patients with Parkinson's Disease during COVID‐19 Lockdown
por: Schirinzi, Tommaso, et al.
Publicado: (2020)

Intensive exercise ameliorates motor and cognitive symptoms in experimental Parkinson’s disease restoring striatal synaptic plasticity
por: Marino, Gioia, et al.
Publicado: (2023)

Neuroprotective Role of Dietary Supplementation with Omega-3 Fatty Acids in the Presence of Basal Forebrain Cholinergic Neurons Degeneration in Aged Mice
por: Cutuli, Debora, et al.
Publicado: (2020)

Correction: Cutuli et al. Neuroprotective Role of Dietary Supplementation with Omega-3 Fatty Acids in the Presence of Basal Forebrain Cholinergic Neurons Degeneration in Aged Mice. Int. J. Mol. Sci. 2020, 21, 1741
por: Cutuli, Debora, et al.
Publicado: (2022)

Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence
por: Schirinzi, Tommaso, et al.
Publicado: (2019)

Pisa Syndrome in Parkinson's Disease: Evidence for Bilateral Vestibulospinal Dysfunction
por: Di Lazzaro, Giulia, et al.
Publicado: (2018)

Self-reported needs of patients with Parkinson’s disease during COVID-19 emergency in Italy
por: Schirinzi, Tommaso, et al.
Publicado: (2020)

Tau and Amyloid-β Peptides in Serum of Patients With Parkinson's Disease: Correlations With CSF Levels and Clinical Parameters
por: Schirinzi, Tommaso, et al.
Publicado: (2022)

Lipidomics of Bioactive Lipids in Alzheimer’s and Parkinson’s Diseases: Where Are We?
por: Chiurchiù, Valerio, et al.
Publicado: (2022)

Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay
por: Cariulo, Cristina, et al.
Publicado: (2019)

Dopamine-dependent early synaptic and motor dysfunctions induced by α-synuclein in the nigrostriatal circuit
por: Tozzi, Alessandro, et al.
Publicado: (2021)

When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression
por: Liguori, Claudio, et al.
Publicado: (2018)

Calcium handling: a strategy to fight neurodegeneration in Alzheimer’s disease
por: La Barbera, Livia, et al.
Publicado: (2023)

Resolvins and inflammatory pain
por: Sommer, Claudia, et al.
Publicado: (2011)

Resolvins on the way to resolution
por: Ward, Peter A.
Publicado: (2015)

Acute focal brain damage alters mitochondrial dynamics and autophagy in axotomized neurons
por: Cavallucci, V, et al.
Publicado: (2014)

Centrality of Early Synaptopathy in Parkinson’s Disease
por: Imbriani, Paola, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hbbd2ptb5grafkmn5hlri60tk4